Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanalysis Scientific (TSE:NSCI)
TSXV:NSCI
RESEARCH TOOLSreports
Nanalysis Scientific (NSCI) Stock Price & Analysis
6 Followers
NSCI Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.35 - C$0.66
Previous CloseC$0.48
Volume6.00K
Average Volume (3M)82.78K
Market Cap
C$48.68M
Enterprise ValueC$65.54M
Total Cash (Recent Filing)C$1.27M
Total Debt (Recent Filing)C$18.13M
Price to Earnings (P/E)-2.9
Beta0.94
Next Earnings
May 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding102,000,000
10 Day Avg. Volume62,497
30 Day Avg. Volume82,785
Standard Deviation0.21
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)12.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.19Price Target Upside147.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Nanalysis Scientific News
PremiumCompany Announcements
Nanalysis Observes Revenue Growth Amid Losses
PremiumCompany Announcements
Nanalysis Sets New Dates for Earnings Call
PremiumCompany Announcements
Nanalysis Set to Discuss 2023 Financial Results
PremiumCompany Announcements
Nanalysis Scientific Director Steps Down
PremiumCompany Announcements
Nanalysis Gains Funding for AI Drug Detection Tech
PremiumCompany Announcements
Nanalysis Completes Multimillion-Dollar Funding Round
PremiumCompany Announcements
Nanalysis Scientific Launches $6M Funding RoundBulls Say, Bears Say
Bulls Say
EarningsEBITDA positivity achieved in the CATSA project contributes to a brighter earnings outlook, with expectations of a sustained revenue increase.
Financial PerformanceRevenue exceeded estimates and demonstrated the company's ability to grow its base NMR business and manage the CATSA project rollout.
FundingNanalysis has secured non-dilutive grant funding for R&D in AI-based software, enhancing its financial stability and future innovation potential.
Bears Say
Corporate FinancingThe cash will be used to solidify its balance sheet and for working capital needs.
Financial PerformanceGross margin contracted to 17.5%.
Stock ValuationPrice target reduced to $1.20/share from $1.40/share due to the dilutive impact of the offering.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.57% Insiders
0.00% Mutual Funds
0.03% Other Institutional Investors
90.40% Public Companies and
Individual Investors
NSCI FAQ
What was Nanalysis Scientific’s price range in the past 12 months?
Nanalysis Scientific lowest stock price was C$0.34 and its highest was C$0.66 in the past 12 months.
What is Nanalysis Scientific’s market cap?
Currently, no data Available
When is Nanalysis Scientific’s upcoming earnings report date?
Nanalysis Scientific’s upcoming earnings report date is May 29, 2024 which is in 14 days.
How were Nanalysis Scientific’s earnings last quarter?
Currently, no data Available
Is Nanalysis Scientific overvalued?
According to Wall Street analysts Nanalysis Scientific’s price is currently Undervalued.
Does Nanalysis Scientific pay dividends?
Nanalysis Scientific does not currently pay dividends.
What is Nanalysis Scientific’s EPS estimate?
Nanalysis Scientific’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanalysis Scientific have?
Nanalysis Scientific has 101,425,440 shares outstanding.
What happened to Nanalysis Scientific’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nanalysis Scientific?
Currently, no hedge funds are holding shares in TSE:NSCI
---
Nanalysis Scientific Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$1.19 (147.35% Upside)
C$1.19 (147.35% Upside)
Insider Transactions
Bought Shares
Worth $42.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.66%
12-Months-Change
Fundamentals
Return on Equity
-54.98%
Trailing 12-Months
Asset Growth
-20.88%
Trailing 12-Months
Company Description
Nanalysis Scientific
Nanalysis Scientific Corp develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The company's NMReady-60, the fully featured 60 MHz benchtop NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens, is used for all types of industrial applications. It will begin selling a 100MHz device in early 2020. The company's new device will be the powerful non-cryogen, permanent magnet NMR device.
---
NSCI Earnings Call
Q4 2024
0:00 / 0:00
---
NSCI Stock 12 Month Forecast
Average Price Target
C$1.19
▲(147.35% Upside)
Technical Analysis
Best Analysts Covering NSCI
1 Year
1 Year Success Rate
4/13 ratings generated profit
1 Year Average Return
-23.85%
reiterated a buy rating 16 days ago
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -23.85% per trade.
---